SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,029,000 | -46.8% | 248,610 | -25.4% | 0.01% | -54.5% |
| Q1 2022 | $1,935,000 | -78.9% | 333,082 | -43.4% | 0.01% | -85.7% |
| Q4 2020 | $9,185,000 | +2562.3% | 588,624 | +1430.7% | 0.08% | +1825.0% |
| Q2 2020 | $345,000 | +255.7% | 38,454 | +277.4% | 0.00% | +33.3% |
| Q1 2019 | $97,000 | -94.8% | 10,190 | -89.6% | 0.00% | -93.2% |
| Q1 2018 | $1,867,000 | -45.1% | 98,244 | -52.6% | 0.04% | -40.5% |
| Q4 2017 | $3,402,000 | – | 207,433 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |